Angiotensin receptor blocker often a valuable alternative to ACE inhibitors
Partanen, J.
Duodecim; Laaketieteellinen Aikakauskirja 119(13): 1193-1196
2003
ISSN/ISBN: 0012-7183 PMID: 12908180 Document Number: 556157
Document emailed within 1 workday
Related Documents
Krzesinski, J.M.; Montrieux, C.; Scheen, A.J. 2006: Angiotensin converting enzyme inhibitors or angiotensin Ii receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us? Revue Medicale de Liege 61(5-6): 414-422Anantharaman, R.; Bhansali, A.; Bhadada, S.K.; Kohli, H.S.; Dutta, P.; Walia, R.; Jayaprakash, P.; Upreti, V. 2010: Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor and angiotensin receptor blocker in type 1 DM with nephropathy Indian Journal of Medical Research 132: 42-47
Diskin, C.J.; Stokes, T.J.; Dansby, L.M.; Radcliff, L.; Carter, T.B. 2007: Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker? Journal of Nephrology 20(4): 410-416
De Paz, S.; Martín, A.B.; Iglesias, A.; Domínguez, A.R. 1999: Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin Ii receptor antagonists Medicina Clinica 113(19): 759
Katagiri, T.; Takei, M.; Sakurai, M.; Matsuyama, T.; Sakai, T. 2006: Antiinflammatory action of angiotensin receptor blocker Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 5): 506-511
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Surabenjawong, U.; Thunpiphat, N.; Chatsiricharoenkul, S.; Monsomboon, A. 2013: Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers Journal of the Medical Association of Thailand 96(8): 905-910
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin converting enzyme inhibitors and angiotensin Ii receptor blockers on angiogenesis of gastric cancer in a nude mouse model Zhonghua Wei Chang Wai Ke Za Zhi 11(6): 565-568
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin-converting enzyme inhibitors and angiotensin Ii type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model Chinese Medical Journal 121(21): 2167-2171
Renke, M.; Rutkowski, Pław.; Tylicki, L.; Zietkiewicz, M.; Larczyński, W.; Rutkowski, Bław. 2008: Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline Przeglad Lekarski 65(6): 312-314
Vijan, S.G. 2009: Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients Journal of the Indian Medical Association 107(3): 178-182
Huang, J. 2006: The important role of angiotensin receptor blocker on treatment of chronic heart failure Zhonghua Xin Xue Guan Bing Za Zhi 34(9): 773-774
Miyata, M.; Eto, H.; Biro, S.; Tei, C. 2002: Preventing effect of angiotensin II receptor blocker on neointimal hyperplasia after vascular injury Nihon Rinsho. Japanese Journal of Clinical Medicine 60(10): 1957-1961
Umemura, S. 2008: Significance of treating prehypertension with an angiotensin-receptor blocker--results from TROPHY study Nihon Rinsho. Japanese Journal of Clinical Medicine 66(3): 601-609
Tachikawa, H.; Kodama, M.; Hui, L.; Yoshida, T.; Hayashi, M.; Abe, S.; Kashimura, T.; Kato, K.; Hanawa, H.; Watanabe, K.; Nakazawa, M.; Aizawa, Y. 2003: Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis Journal of Cardiovascular Pharmacology 41(Suppl): S105-S110
Beloborodova, A.V.; Morozova, T.E.; Shilov, E.M. 2010: An experience of the use of angiotensin Ii receptor blocker losartan in patients with metabolic syndrome and chronic kidney disease Kardiologiia 50(8): 32-36
Buranakitjaroen, P.; Phoojaroenchanachai, M.; Saravich, S.; Sangprasert, P. 2002: The efficacy and tolerability of an angiotensin Ii receptor blocker, telmisartan, in Thai patients with mild to moderate essential hypertension Journal of the Medical Association of Thailand 85(9): 968-977
Tao, Z-wei.; Huang, Y-wei.; Xia, Q.; Xu, Q-wen. 2005: Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction Chinese Medical Journal 118(2): 146-154
Shibata, S.; Matsunaga, M.; Oikawa, M.; Nitahara, K.; Higa, K. 2005: Severe hypotension after induction of general anesthesia in a patient receiving an angiotensin II receptor antagonist and an alpha-blocker Masui. Japanese Journal of Anesthesiology 54(6): 670-672
Iwata, A.; Miura, S.-i.; Nishikawa, H.; Kawamura, A.; Matsuo, Y.; Sako, H.; Kumagai, K.; Matsuo, K.; Saku, K. 2006: Significance of combined angiotensin Ii receptor blocker and carvedilol therapy in patients with congestive heart failure and arginine variant Journal of Cardiology 47(1): 1-7